Effect of External Counter Pulsation on Ischemic Stroke

Not yet recruiting

Phase 3 Results N/A

Summary of Purpose

Stroke is a prevalent atherosclerosis vascular disease with high mortality, external counter pulsation (ECP) is an approved noninvasive therapy for angina, congestive heart failure, myocardial infarction, and cardiogenic shock that augments blood flow to cardiac and systemic circuits, which improves the flow volume in the carotid. Though ECP is Ⅱa recommendation for stroke management, no multi-center control...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 April 2017.

10 Jun 2017 28 Feb 2017 31 May 2018 30 Jun 2018 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts